April 25, 2011
I’ve posted about NASDAQ’s competing bid for NYSE and its possible risks. Seems that the NYSE board feels the same way, announcing: This proposal does not provide compelling value, has unacceptable execution risk and is therefore not in the best interests of NYSE Euronext shareholders. Ultimately, any litigation will turn on the “unacceptable execution risk” […]
Read the full article →
April 20, 2011
I briefly posted about the decision the NYSE board has to make from a purely investor/corporate governance perspective. The Deal Professor offers another perspective: The NYSE board also has to consider the antitrust issues involved with agreeing to be bought by NASDAQ. Right now, NASDAQ and NYSE are two, direct, competitors in that industry. Therefore, […]
Read the full article →